MEDIA

Latest News

Revance is a biotechnology company focused on innovative aesthetic and therapeutic offerings, as well as financial technology services for aesthetic practices.

Practical Dermatology Logo

FDA Accepts Revance’s BLA Resubmission for DaxibotulinumtoxinA

Formulary Watch Logo

FDA Accepts Resubmitted BLA for Cosmetic Therapy

My Medical Daily Logo

FDA Accepts Revance Resubmission for Frown Line Therapy

Endpoint News Logo

Will A Biotech Rival Finally Shake Up Abbvie’s $2B Botox Cosmetic Franchise? Revance Will Find Out Soon